Personal profile
Research interests
Onderzoeksbelangen
Fingerprint
Dive into the research topics where Kirsten Vrenken is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges
Stutterheim, J., van der Sluis, I. M., Vrenken, K. S., Pieters, R. & Stam, R. W., 1 Sept 2025, In: Haematologica. 110, 9, p. 1951-1961 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access6 Citations (Scopus) -
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in KMT2A-Rearranged Acute Lymphoblastic Leukemia
Schneider, P., Wander, P., Arentsen-Peters, S. T. C. J. M., Vrenken, K. S., Rockx-Brouwer, D., Adriaanse, F. R. S., Hoeve, V., Paassen, I., Drost, J., Pieters, R. & Stam, R. W., Sept 2023, In: International journal of molecular sciences. 24, 17, 13207.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
High-Throughput Drug Library Screening in Primary KMT2A-Rearranged Infant ALL Cells Favors the Identification of Drug Candidates That Activate P53 Signaling
Wander, P., Arentsen-Peters, S. T. C. J. M., Vrenken, K. S., Pinhanҫos, S. M., Koopmans, B., Dolman, M. E. M., Jones, L., Castro, P. G., Schneider, P., Kerstjens, M., Molenaar, J. J., Pieters, R., Zwaan, C. M. & Stam, R. W., Mar 2022, In: Biomedicines. 10, 3, 638.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus) -
Nectin stabilization at adherens junctions is counteracted by Rab5a-dependent endocytosis
Cervero, P., Vrenken, K., Klose, M., Rehm, K. & Linder, S., 1 Sept 2021, In: European journal of cell biology. 100, 7-8, 151184.Research output: Contribution to journal › Review article › peer-review
Open Access2 Citations (Scopus) -
The transcriptional repressor SNAI2 impairs neuroblastoma differentiation and inhibits response to retinoic acid therapy
Vrenken, K. S., Vervoort, B. M. T., van Ingen Schenau, D. S., Derks, Y. H. W., van Emst, L., Grytsenko, P. G., Middelbeek, J. A. J. & van Leeuwen, F. N., 1 Mar 2020, In: Biochimica et biophysica acta. Molecular basis of disease. 1866, 3, p. 165644 165644.Research output: Contribution to journal › Article › peer-review
Open Access13 Citations (Scopus)